Tel W, McClatchey KD, Quint D: Case report 427: Cerebrotendinous xanthomatosis. Skelet
Tel W, McClatchey KD, Quint D: Case report 427: Cerebrotendinous xanthomatosis. Skelet Radiol 1987, 16(4):346?49. 102. Laurent A, Dairou F, Luc G, Truffert J, Lapresle J, de Gennes JL: Van Bogaert’s cerebrotendinous xanthomatosis. A study of 3 cases. Ann Med Interne 1988, 139(6):395?02. 103. Wevers RA, Cruysberg JR, Van Heijst AF, Janssen-Zijlstra FS, Renier WO, Van Engelen BG, Tolboom JJ: Paediatric cerebrotendinous xanthomatosis. J Inherit Metab Dis 1992, 15(3):374?76. 104. Soffer D, Benharroch D, Berginer V: The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature. Acta Neuropathol 1995, 90(2):213?20. 105. Verrips A, Steenbergen-Spanjers GC, Luyten JA, van den Heuvel LP, Keyser A, Gabreels FJ, Wevers RA: Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis. Hum Genet 1996, 98(6):735?37. 106. Sperhake JP, Matschke J, Orth U, Gal A, Puschel K: Sudden death due to cerebrotendinous xanthomatosis confirmed by mutation analysis. Int J Legal Med 2000, 113(2):110?13. 107. Dotti MT, Rufa A, Federico A: Cerebrotendinous xanthomatosis: heterogeneity of clinical phenotype with evidence of previously undescribed ophthalmological findings. J Inherit Metab Dis 2001, 24(7):696?06. 108. Lee Y, Lin PY, Chiu NM, Chang WN, Wen JK: Cerebrotendinous xanthomatosis with psychiatric disorders: report of three siblings and literature review. Chang Gung Med J 2002, 25(5):334?40. 109. Guyant-Marechal L, Verrips A, Girard C, Wevers RA, Zijlstra F, Sistermans E, Vera P, Campion D, Hannequin D: Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype. Am J Med Genet A 2005, 139A(2):114?17. 110. Price Evans DA, Salah KA, Mobrad MA, Mitchell WD, Olin M, Eggertsen G: Cerebrotendinous xanthomatosis in a Saudi Arabian family-genotyping and long-term follow-up. Saudi Med J 2007, 28(7):1113?118. 111. Gonzalez-Cuyar LF, Hunter B, Harris PL, Perry G, Smith MA, Castellani RJ: Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress. Redox Rep 2007, 12(3):119?24. 112. Bonnot O, Fraidakis MJ, Lucanto R, Chauvin D, Kelley N, Plaza M, Dubourg O, Lyon-Caen O, Sedel F, Cohen D: Cerebrotendinous xanthomatosis presenting with severe externalized disorder: improvement after one year of PF-04418948 supplier treatment with chenodeoxycholic Acid. CNS Spectr 2010, 15(4):231?36. 113. Group N-CGW, Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topcu M, Vanier MT, Widner H, Wijburg FA, Patterson MC: Recommendations on the diagnosis and management PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/26226583 of Niemann-Pick disease type C. Mol Genet Metab 2009, 98(1?):152?65. 114. Vanier MT: Niemann-Pick disease type C. Orphanet J Rare Dis 2010, 5:16. 115. Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, on behalf of the NPCGWG: Recommendations for the diagnosis andBonnot et al. Orphanet Journal of Rare Diseases 2014, 9:65 http://www.ojrd.com/content/9/1/Page 14 of116.117.118.119.120.121. 122.123.124.125.126.127. 128.129.130.131.132.133.134.135.136.137.management of Niemann-Pick disease type C: An update. Mol Genet Metab 2012, 106(3):330?44. Vanier MT: Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem Res 1999, 24(4):481?89. Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F: The adult form of Niemann-Pick disease type C. Brain 2007, 130(Pt 1):120?33. Trendelenburg G, Vanier MT, Maza S.